Figure 1 — Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma

Research Paper|Volume 11, Issue 16|pp. 6312–6335

Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma

100%

Figure 1.Out of bag (OOB) error rate derived from weighted random forest analysis. Top 62 and 38 DNA methylation probes in the discovery (A) and validation phases (B) reached a minimum OOB error rate. Top 9 and 13 mRNAs in the discovery (C) and validation phases (D) reached a minimum OOB error rate.